Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable ... which has had the market mostly to itself since it was approved by the FDA in ...

The Indian pharmaceuticals market continued to report mid-single-digit growth in August, as sales grew 6.3% annually, ...

The stock market rallied toward the end of August with rate cut expectations. Despite weakness in tech stocks, analysts remain optimistic about the stock market. Inflation and uncertainty ...

As on Sep 18, 2024, Glaxosmithkline Pharmaceuticals Ltd (GLAXO)’s share price on NSE is Rs 2791.3 What is the market cap of Glaxosmithkline Pharmaceuticals Ltd (GLAXO?) The current market ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

DeFi protocol Blast native stablecoin, USDB, depegged on Monday morning as the market registered weakness. At the time of writing, the stablecoin has recovered to trade at par of $1 on CoinMarketCap.

Nigerians are bracing for more economic weakness after the local currency plunged to a record low against the US dollar. The ...